Clinical Trial

Chronic Intervention With Sulforaphane-Smart® in Overweight and Obese Adults

Study acronym: SANO-Chronic
Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The Sulforaphane-Smart® formula is a pill, patented by the company INGREDALIA, prepared with broccoli by-products which have been concentrated and enriched in glucosinolates/isothiocyanates (GLS/ITCs). The goal of this intervention study is to evaluate if the chronic consumption of GSL/ITC (Sulforaphane Smart® formula) could modulate the biomarkers related to chronic inflammation, oxidative stress and gut microbiota in overweight and obese volunteers. In order to reach this goal, the volunteers will take daily the Sulforaphane Smart® formula during 12 weeks (total of 84 days). Anthropometric measurements will be taken and biological samples of blood, urine and feces will be collected at the beginning of the intervention (initial time), after six weeks of the intervention (Time 6 weeks) and at the end of the intervention (Time 12 weeks).
Trial Details
NCT Number NCT06964659
Lead Sponsor Mª Jesús Periago
Collaborators: Ingredalia Company, Spanish National Research Council (CEBAS-CSIC)
Conditions Obesity and Overweight
Enrollment 40 participants
Start Date 2025-07
Primary Completion 2026-09 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-09